All Resources

A Patient With Type 1 Diabetes, Visual Acuity Loss, and Retinal Thickening

The Role of OCT-A in Retinal Disease Management

Topical antibiotics and intravitreal injections

Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases

The role of OCT-A in retinal disease management

Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review

Futility of treatment viewpoint video - David Wong

Bilateral VEGF viewpoint video - Ian Pearce

Vision Academy EASD symposium 2017 - Diabetic eye disease - A treatable complication of diabetes

Vision Academy COPHy Europe symposium 2018_Suspending treatment debates

Topical antibiotics viewpoint video - Alex Hunyor

Fundamental principles of anti VEGF viewpoint video - Paolo Lanzetta

Vision Academy COPHy Europe symposium 2017 Bilateral anti-VEGF debates

Vision Academy COPHy Europe symposium 2018 Optimal anti-VEGF debates

Vision Academy COPHy Europe symposium 2017 Topical antibiotics debates

Vision Academy COPHy AA symposium 2018 Topical antibiotics debates

Vision Academy COPHy AA symposium 2018 Optimal VEGF debates

Vision Academy EASD symposium 2017 - The association between DR and other complications of diabetes

Additional Measures of Visual Function Beyond Acuity

Use of Topical Antibiotics with Intravitreal Injections

Fundamental Principles of an Anti-VEGF Treatment Regimen

Bilateral Anti-VEGF Treatment

Management of Subfoveal Hemorrhage